Login / Signup

Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up.

Roel J R SnijderL E RenesD BosshardtM J SuttorpJ M Ten BergMartijn C Post
Published in: Journal of interventional cardiology (2020)
Percutaneous ASD closure using the Occlutech device appears to be safe at long-term follow-up with a high successful closure rate at one year.
Keyphrases
  • minimally invasive
  • ultrasound guided
  • autism spectrum disorder
  • radiofrequency ablation
  • atrial fibrillation
  • case report
  • attention deficit hyperactivity disorder